▶ 調査レポート

脊髄性筋萎縮症の世界市場（～2026年）
• 英文タイトル：Global Spinal Muscular Atrophy Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。脊髄性筋萎縮症の世界市場（～2026年） / Global Spinal Muscular Atrophy Market Size, Status and Forecast 2020-2026 / MRC2-11QY04711資料のイメージです。• レポートコード：MRC2-11QY04711
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は脊髄性筋萎縮症のグローバル市場について調査・分析したレポートです。種類別（初期段階の候補者、後期段階の候補者）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別脊髄性筋萎縮症の競争状況、市場シェア
・世界の脊髄性筋萎縮症市場：種類別市場規模 2015年-2020年（初期段階の候補者、後期段階の候補者）
・世界の脊髄性筋萎縮症市場：種類別市場規模予測 2021年-2026年（初期段階の候補者、後期段階の候補者）
・世界の脊髄性筋萎縮症市場：用途別市場規模 2015年-2020年（病院、診療所、その他）
・世界の脊髄性筋萎縮症市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他）
・北米の脊髄性筋萎縮症市場分析：米国、カナダ
・ヨーロッパの脊髄性筋萎縮症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの脊髄性筋萎縮症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の脊髄性筋萎縮症市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの脊髄性筋萎縮症市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Lonis Pharmaceuticals、F. Hoffmann-La Roche、AveXis、Novartis、Cytokinetics、Ionis Pharmaceuticals
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Spinal Muscular Atrophy Market
The global Spinal Muscular Atrophy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Spinal Muscular Atrophy Scope and Market Size
Spinal Muscular Atrophy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Lonis Pharmaceuticals
F. Hoffmann-La Roche
AveXis
Novartis
Cytokinetics
Ionis Pharmaceuticals
…

Market segment by Type, the product can be split into
Early Stage Candidates
Late Stage Candidates
Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Spinal Muscular Atrophy Revenue
1.4 Market by Type
1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Early Stage Candidates
1.4.3 Late Stage Candidates
1.5 Market by Application
1.5.1 Global Spinal Muscular Atrophy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Market Perspective (2015-2026)
2.2 Global Spinal Muscular Atrophy Growth Trends by Regions
2.2.1 Spinal Muscular Atrophy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Spinal Muscular Atrophy Historic Market Share by Regions (2015-2020)
2.2.3 Spinal Muscular Atrophy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Spinal Muscular Atrophy Market Growth Strategy
2.3.6 Primary Interviews with Key Spinal Muscular Atrophy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Players by Market Size
3.1.1 Global Top Spinal Muscular Atrophy Players by Revenue (2015-2020)
3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Players (2015-2020)
3.1.3 Global Spinal Muscular Atrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Spinal Muscular Atrophy Market Concentration Ratio
3.2.1 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Revenue in 2019
3.3 Spinal Muscular Atrophy Key Players Head office and Area Served
3.4 Key Players Spinal Muscular Atrophy Product Solution and Service
3.5 Date of Enter into Spinal Muscular Atrophy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Spinal Muscular Atrophy Historic Market Size by Type (2015-2020)
4.2 Global Spinal Muscular Atrophy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Spinal Muscular Atrophy Market Size by Application (2015-2020)
5.2 Global Spinal Muscular Atrophy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Spinal Muscular Atrophy Market Size (2015-2020)
6.2 Spinal Muscular Atrophy Key Players in North America (2019-2020)
6.3 North America Spinal Muscular Atrophy Market Size by Type (2015-2020)
6.4 North America Spinal Muscular Atrophy Market Size by Application (2015-2020)

7 Europe
7.1 Europe Spinal Muscular Atrophy Market Size (2015-2020)
7.2 Spinal Muscular Atrophy Key Players in Europe (2019-2020)
7.3 Europe Spinal Muscular Atrophy Market Size by Type (2015-2020)
7.4 Europe Spinal Muscular Atrophy Market Size by Application (2015-2020)

8 China
8.1 China Spinal Muscular Atrophy Market Size (2015-2020)
8.2 Spinal Muscular Atrophy Key Players in China (2019-2020)
8.3 China Spinal Muscular Atrophy Market Size by Type (2015-2020)
8.4 China Spinal Muscular Atrophy Market Size by Application (2015-2020)

9 Japan
9.1 Japan Spinal Muscular Atrophy Market Size (2015-2020)
9.2 Spinal Muscular Atrophy Key Players in Japan (2019-2020)
9.3 Japan Spinal Muscular Atrophy Market Size by Type (2015-2020)
9.4 Japan Spinal Muscular Atrophy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Spinal Muscular Atrophy Market Size (2015-2020)
10.2 Spinal Muscular Atrophy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type (2015-2020)
10.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application (2015-2020)

11 India
11.1 India Spinal Muscular Atrophy Market Size (2015-2020)
11.2 Spinal Muscular Atrophy Key Players in India (2019-2020)
11.3 India Spinal Muscular Atrophy Market Size by Type (2015-2020)
11.4 India Spinal Muscular Atrophy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Spinal Muscular Atrophy Market Size (2015-2020)
12.2 Spinal Muscular Atrophy Key Players in Central & South America (2019-2020)
12.3 Central & South America Spinal Muscular Atrophy Market Size by Type (2015-2020)
12.4 Central & South America Spinal Muscular Atrophy Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Lonis Pharmaceuticals
13.1.1 Lonis Pharmaceuticals Company Details
13.1.2 Lonis Pharmaceuticals Business Overview
13.1.3 Lonis Pharmaceuticals Spinal Muscular Atrophy Introduction
13.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2015-2020))
13.1.5 Lonis Pharmaceuticals Recent Development
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Details
13.2.2 F. Hoffmann-La Roche Business Overview
13.2.3 F. Hoffmann-La Roche Spinal Muscular Atrophy Introduction
13.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Recent Development
13.3 AveXis
13.3.1 AveXis Company Details
13.3.2 AveXis Business Overview
13.3.3 AveXis Spinal Muscular Atrophy Introduction
13.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2015-2020)
13.3.5 AveXis Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Spinal Muscular Atrophy Introduction
13.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Cytokinetics
13.5.1 Cytokinetics Company Details
13.5.2 Cytokinetics Business Overview
13.5.3 Cytokinetics Spinal Muscular Atrophy Introduction
13.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2015-2020)
13.5.5 Cytokinetics Recent Development
13.6 Ionis Pharmaceuticals
13.6.1 Ionis Pharmaceuticals Company Details
13.6.2 Ionis Pharmaceuticals Business Overview
13.6.3 Ionis Pharmaceuticals Spinal Muscular Atrophy Introduction
13.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2015-2020)
13.6.5 Ionis Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Spinal Muscular Atrophy Key Market Segments
Table 2. Key Players Covered: Ranking by Spinal Muscular Atrophy Revenue
Table 3. Ranking of Global Top Spinal Muscular Atrophy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Spinal Muscular Atrophy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Early Stage Candidates
Table 6. Key Players of Late Stage Candidates
Table 7. Global Spinal Muscular Atrophy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Spinal Muscular Atrophy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Spinal Muscular Atrophy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Spinal Muscular Atrophy Market Share by Regions (2015-2020)
Table 11. Global Spinal Muscular Atrophy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Spinal Muscular Atrophy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Spinal Muscular Atrophy Market Growth Strategy
Table 17. Main Points Interviewed from Key Spinal Muscular Atrophy Players
Table 18. Global Spinal Muscular Atrophy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Spinal Muscular Atrophy Market Share by Players (2015-2020)
Table 20. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy as of 2019)
Table 21. Global Spinal Muscular Atrophy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Spinal Muscular Atrophy Product Solution and Service
Table 24. Date of Enter into Spinal Muscular Atrophy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Spinal Muscular Atrophy Market Size Share by Type (2015-2020)
Table 28. Global Spinal Muscular Atrophy Revenue Market Share by Type (2021-2026)
Table 29. Global Spinal Muscular Atrophy Market Size Share by Application (2015-2020)
Table 30. Global Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Spinal Muscular Atrophy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 34. North America Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 36. North America Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 38. Europe Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 40. Europe Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 42. Europe Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 44. China Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 46. China Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 47. China Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 48. China Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 49. China Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 50. Japan Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 52. Japan Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 54. Japan Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 58. Southeast Asia Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 60. Southeast Asia Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 62. India Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 64. India Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 65. India Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 66. India Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 67. India Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Spinal Muscular Atrophy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Spinal Muscular Atrophy Market Share (2019-2020)
Table 70. Central & South America Spinal Muscular Atrophy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Spinal Muscular Atrophy Market Share by Type (2015-2020)
Table 72. Central & South America Spinal Muscular Atrophy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Spinal Muscular Atrophy Market Share by Application (2015-2020)
Table 74. Lonis Pharmaceuticals Company Details
Table 75. Lonis Pharmaceuticals Business Overview
Table 76. Lonis Pharmaceuticals Product
Table 77. Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2015-2020) (Million US$)
Table 78. Lonis Pharmaceuticals Recent Development
Table 79. F. Hoffmann-La Roche Company Details
Table 80. F. Hoffmann-La Roche Business Overview
Table 81. F. Hoffmann-La Roche Product
Table 82. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2015-2020) (Million US$)
Table 83. F. Hoffmann-La Roche Recent Development
Table 84. AveXis Company Details
Table 85. AveXis Business Overview
Table 86. AveXis Product
Table 87. AveXis Revenue in Spinal Muscular Atrophy Business (2015-2020) (Million US$)
Table 88. AveXis Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Spinal Muscular Atrophy Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Cytokinetics Company Details
Table 95. Cytokinetics Business Overview
Table 96. Cytokinetics Product
Table 97. Cytokinetics Revenue in Spinal Muscular Atrophy Business (2015-2020) (Million US$)
Table 98. Cytokinetics Recent Development
Table 99. Ionis Pharmaceuticals Company Details
Table 100. Ionis Pharmaceuticals Business Overview
Table 101. Ionis Pharmaceuticals Product
Table 102. Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2015-2020) (Million US$)
Table 103. Ionis Pharmaceuticals Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Market Share by Type: 2020 VS 2026
Figure 2. Early Stage Candidates Features
Figure 3. Late Stage Candidates Features
Figure 4. Global Spinal Muscular Atrophy Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Spinal Muscular Atrophy Report Years Considered
Figure 9. Global Spinal Muscular Atrophy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Spinal Muscular Atrophy Market Share by Regions: 2020 VS 2026
Figure 11. Global Spinal Muscular Atrophy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Spinal Muscular Atrophy Market Share by Players in 2019
Figure 14. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Revenue in 2019
Figure 16. North America Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Spinal Muscular Atrophy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介
  • 脊髄性筋萎縮症（SMA）治療の世界市場（～2026年）
    Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04710 2020年11月20日 91Pages
    当調査資料は脊髄性筋萎縮症（SMA）治療のグローバル市場について調査・分析したレポートです。種類別（I型脊髄性筋萎縮症（SMA）、II型脊髄性筋萎縮症（SMA）、III型脊髄性筋萎縮症（SMA））市場規模、用途別（病院、外来外科センター、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨ...
  • 多系統萎縮症治療薬の世界市場（～2026年）
    Global Multiple System Atrophy Therapeutics Market Insights and Forecast to 2026
    MRC2-11QY07931 2020年11月20日 117Pages
    当調査資料は多系統萎縮症治療薬のグローバル市場について調査・分析したレポートです。種類別（Anle-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...
  • ベッカー型筋ジストロフィー治療薬の世界市場（～2026年）
    Global Becker Muscular Dystrophy Drug Market Insights and Forecast to 2026
    MRC2-11QY03028 2020年11月20日 114Pages
    当調査資料はベッカー型筋ジストロフィー治療薬のグローバル市場について調査・分析したレポートです。種類別（ジビノスタット、アタルレン、エピカテキン、ARM-210、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...
  • デュシェンヌ型筋ジストロフィー薬の世界市場（～2026年）
    Global Duchenne Muscular Dystrophy Drugs Market Insights and Forecast to 2026
    MRC2-11QY05476 2020年11月20日 185Pages
    当調査資料はデュシェンヌ型筋ジストロフィー薬のグローバル市場について調査・分析したレポートです。種類別（開発・創薬ターゲット、作用機序（MoA）、投与経路（RoA）、分子タイプ）市場規模、用途別（病院・診療所、臨床検査室、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...
  • 脊髄刺激システムの世界市場（～2026年）
    Global Spinal Cord Stimulation System Market Size, Status and Forecast 2020-2026
    MRC2-11QY04706 2020年11月20日 95Pages
    当調査資料は脊髄刺激システムのグローバル市場について調査・分析したレポートです。種類別（従来型脊髄刺激システム、高周波脊髄刺激システム、充電式脊髄刺激システム）市場規模、用途別（病院、理学療法センター、外来外科センター、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...
  • 脊椎手術の世界市場（～2026年）
    Global Spinal Surgery Market Size, Status and Forecast 2020-2026
    MRC2-11QY04713 2020年11月20日 94Pages
    当調査資料は脊椎手術のグローバル市場について調査・分析したレポートです。種類別（顕微鏡、脊椎ブラケット、X線装置、その他）市場規模、用途別（病院、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...
  • 変形性脊椎システムの世界市場（～2026年）
    Global Deformity Spinal System Market Size, Status and Forecast 2020-2026
    MRC2-11QY11587 2020年11月25日 98Pages
    当調査資料は変形性脊椎システムのグローバル市場について調査・分析したレポートです。種類別（ロッド、フック、プレート、ケージ、椎弓根スクリュー）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...
  • 転移性脊椎腫瘍の世界市場（～2026年）
    Global Metastases Spinal Tumor Market Size, Status and Forecast 2020-2026
    MRC2-11QY12664 2020年11月25日 96Pages
    当調査資料は転移性脊椎腫瘍のグローバル市場について調査・分析したレポートです。種類別（臨床検査、画像検査、生検）市場規模、用途別（病院・クリニック、外来手術センター、学術機関、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...
  • 急性脊髄損傷の世界市場（～2026年）
    Global Acute Spinal Cord Injury Market Size, Status and Forecast 2020-2026
    MRC2-11QY13571 2020年11月30日 93Pages
    当調査資料は急性脊髄損傷のグローバル市場について調査・分析したレポートです。種類別（実験室検査、画像検査）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...
  • 脊椎画像ガイダンスシステムの世界市場（～2026年）
    Global Spinal Image Guidance Systems Market Size, Status and Forecast 2020-2026
    MRC2-11QY04708 2020年11月20日 93Pages
    当調査資料は脊椎画像ガイダンスシステムのグローバル市場について調査・分析したレポートです。種類別（X線、磁気共鳴画像法（MRI）、コンピューター断層撮影（CT）、3D蛍光透視法）市場規模、用途別（病院、外来外科センター、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...
  • 脊髄性筋萎縮症（SMA）治療の世界市場（～2026年）脊髄性筋萎縮症（SMA）治療の世界市場（～2026年） Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration. North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region. Market …
  • 多系統萎縮症治療薬の世界市場（～2026年）多系統萎縮症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Multiple System Atrophy Therapeutics Market The global Multiple System Atrophy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Multiple System Atrophy Therapeutics Scop…
  • ベッカー型筋ジストロフィー治療薬の世界市場（～2026年）ベッカー型筋ジストロフィー治療薬の世界市場（～2026年） Market Analysis and Insights: Global Becker Muscular Dystrophy Drug Market The global Becker Muscular Dystrophy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Becker Muscular Dystrophy Drug Scope and Market Size …
  • 脊椎手術の世界市場（～2026年）脊椎手術の世界市場（～2026年） Back pain is a symptom of medical condition and the most common cause of back pain is a condition called intervertebral disc degeneration which means that the disc located between the vertebrae of the spine are breaking down with age. An increasing preference for Minimally Invasive Spinal Surgery, l…
  • 脊髄刺激システムの世界市場（～2026年）脊髄刺激システムの世界市場（～2026年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…